The pharmaceutical giant is expected to report earnings today of $1.44 a share on revenue of $21.3 billion.

The pharmaceutical giant is expected to report earnings of $1.44 a share on revenue of $21.3 billion. From a technical overview, its shares are currently trading at $46.89 a share. Towards the downside, support levels sit at $46.51 then at $45.63 then a major support level at $45.09 (green oval). A break below the major support level could see the share price fall towards the green support trendline which would act as the following support level. Towards the upside, resistance sits at $47.23 then at $47.40 then a major resistance level at $47.56 (red oval). A surge above the major resistance may see the stock climb towards the $48-$49 price range. Looking at the indicators, MACD has just turned negative but RSI is positive as it reads 62.